Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

被引:8
作者
Kyritsi, Eleni-Magdalini [1 ]
Koltsida, Georgia [1 ]
Farakla, Ioanna [1 ]
Papanikolaou, Aikaterini [2 ]
Critselis, Elena [1 ]
Mantzou, Emilia [1 ]
Zoumakis, Emmanouil [1 ]
Kolaitis, Gerasimos [2 ]
Chrousos, George P. [1 ,3 ]
Charmandari, Evangelia [1 ,3 ]
机构
[1] Natl & Kapodistrian Univ Athens, Med Sch, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet,Dept Pediat 1, Thivon & Papadiamantopoulou St, Athens 11527, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Aghia Sophia Childrens Hosp, Dept Child Psychiat, Athens, Greece
[3] Acad Athens, Div Endocrinol & Metab, Biomed Res Fdn, Clin Res Ctr, Athens, Greece
来源
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2017年 / 16卷 / 01期
关键词
Anxiety; Carriers; Congenital adrenal hyperplasia; Depression; 21-hydroxylase deficiency; HORMONE-RECEPTOR ANTAGONIST; HPA AXIS; SALIVARY CORTISOL; DEPRESSION; ANXIETY; SYSTEM; DISORDERS; CRH; NEUROENDOCRINE; INVENTORY;
D O I
10.14310/horm.2002.1718
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: Carriers of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) demonstrate increased secretion of cortisol precursors following ACTH stimulation, suggestive of impaired cortisol production and compensatory increases in hypothalamic corticotropin-releasing hormone (CRH) secretion. Both cortisol and CRH have behavioral effects, and hypothalamic CRH hypersecretion has been associated with chronic states of anxiety and depression. We performed an endocrinologic and psychological evaluation in carriers of 21-OHD and matched control subjects. DESIGN: We recruited 29 parents of children with classic CAH (14 males, 15 females; age (mean +/- SD): 41.8 +/- 5.7 yr), and hence 21-OHD carriers, and 13 normal subjects (5 males, 8 females; age: 43.8 +/- 6.1 yr). All subjects underwent a formal ovine (o) CRH stimulation test with measurement of ACTH, cortisol, 17-hydroxyprogesterone (17-OHP) and androstenedione concentrations, which was preceded by determination of 24-hour urinary free cortisol (UFC) excretion. Psychometric assessment was performed by administering the State-Anxiety (STAI 1) and Trait-Anxiety (STAI 2) Inventory, Beck Depression Inventory, Symptom Checklist-90R and Temperament and Character Inventory. RESULTS : Carriers of 21-OHD had significantly higher 17-OHP concentrations following oCRH stimulation and higher STAI 1 (47.6 +/- 5.6 vs. 43.3 +/- 5.4, P=0.023) scores than control subjects. Mean 24-hour UFC concentrations were positively correlated with paranoid ideation (r=0.435; P=0.023) and psychoticism (r=0.454; P=0.017). Stepwise multiple linear regression analysis revealed that the single independent predictor of STAI 1 was peak stimulated 17-OHP concentrations (beta: 0.055, SE: 0.023, R-2: 0.290, P=0.031). CONCLUSIONS : Carriers of 21-OHD may be predisposed to the development of anxiety disorders.
引用
收藏
页码:42 / 53
页数:12
相关论文
共 50 条
  • [21] Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Espinosa Reyes, Tania Mayvel
    Collazo Mesa, Teresa
    Lantigua Cruz, Paulina Arasely
    Agramonte Machado, Adriana
    Dominguez Alonso, Emma
    Falhammar, Henrik
    BMC ENDOCRINE DISORDERS, 2020, 20 (01)
  • [22] Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults
    Bachelot, Anne
    Chakthoura, Zeina
    Rouxel, Agnes
    Dulon, Jerome
    Touraine, Philippe
    HORMONE RESEARCH, 2008, 69 (04) : 203 - 211
  • [23] Height outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    冯韵霖
    朱慧娟
    龚凤英
    李乃适
    潘慧
    陆召麟
    史轶蘩
    生殖医学杂志, 2007, (S1) : 16 - 19
  • [24] Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Tania Mayvel Espinosa Reyes
    Teresa Collazo Mesa
    Paulina Arasely Lantigua Cruz
    Adriana Agramonte Machado
    Emma Domínguez Alonso
    Henrik Falhammar
    BMC Endocrine Disorders, 20
  • [25] Pitfall of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Rohrer, TR
    Gassmann, KF
    Pavel, ME
    Dörr, HG
    BIOLOGY OF THE NEONATE, 2003, 83 (01): : 65 - 68
  • [26] Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns
    Abali, Zehra Yavas
    Kurnaz, Erdal
    Guran, Tulay
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2025, 17 : 33 - 43
  • [27] Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: The Italian experience
    Brunelli, VL
    Russo, G
    Bertelloni, S
    Gargantini, L
    Balducci, R
    Chiesa, L
    Livieri, C
    De Sanctis, C
    Einaudi, S
    Virdis, R
    Saggese, G
    Chiumello, G
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 : 277 - 283
  • [28] Clinical, Biochemical and Molecular Characteristics of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency
    Gunes, Sevinc Odabasi
    Kendirci, Havva Nur Peltek
    Unal, Edip
    Bulus, Ayse Derya
    Dundar, Ismail
    Siklar, Zeynep
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2025, 17 : 3 - 11
  • [29] Pregnancy outcomes in women with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Dumic, M
    Janjanin, N
    Ille, J
    Zunec, R
    Spehar, A
    Zlopasa, G
    Francetic, I
    New, MI
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 (09) : 887 - 895
  • [30] Life With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: Challenges and Burdens
    Witchel, Selma Feldman
    Miller, Tahlyn
    Mccann, Erika
    Gupta, Anshu
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 : S56 - S66